2026-10-06T09:49:40Z https://api.figshare.com/v2/oai

oai:figshare.com:article/34032723 2026-09-30T14:22:51Z category_24139 item_type_3 month_year_09_2026

Estrogen-mediated reprogramming augments cardiac progenitor cell therapy for heart failure- Supporting informations VERDA BİTİRİM (25144314) Cell development, proliferation and death heart failure awareness progenitor cell function estrogen activatable single <p dir="ltr"><b>Supporting Information</b></p><p dir="ltr"><b>Supporting Information PDF:</b> Supplementary figures, tables, and associated legends.</p><p dir="ltr"><b>Supplementary Table S1.</b> Primer sequences used for gene expression analyses.</p><p dir="ltr"><b>Supplementary Table S2.</b> Correlation-based evidence supporting the exclusion of Control-CPC #2 from the RNA-sequencing analysis.</p><p dir="ltr"><b>Supplementary Table S3.</b> Effect of Control-CPC #2 exclusion on differential gene expression results.</p><p dir="ltr"><b>Supplementary Table S4.</b> Complete DESeq2 differential expression results for all genes analyzed in estrogen-treated and control cardiac progenitor cells.</p><p dir="ltr"><b>Supplementary Table S5.</b> Over-representation analysis (ORA) results for differentially expressed genes.</p><p dir="ltr"><b>Supplementary Table S6.</b> Complete list of gene sets included in the pathway-level analyses.</p><p dir="ltr"><b>Supplementary Table S7.</b> Differentially expressed gene membership within the analyzed gene sets.</p> 2026-09-30T14:22:51Z Dataset Dataset 10.6084/m9.figshare.34032723.v1 https://figshare.com/articles/dataset/Estrogen-mediated_reprogramming_augments_cardiac_progenitor_cell_therapy_for_heart_failure-_Supporting_informations/34032723 CC BY 4.0